Short-term use of Infliximab in a case of recalcitrant idiopathic orbital inflammatory disease

Clinical and Experimental Ophthalmology

Volumn 37, Issue 9, 2009, Pages 897-900

  Osborne, Sarah F ^a   Ranzco, Jo L Sims ^a   Ranzco, Paul M Rosser ^a  

^a Greenlane Clinical Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; METHYLPREDNISOLONE; PREDNISONE;

ADULT; CASE REPORT; CHEMOSIS; DIVERGENT STRABISMUS; DRUG DOSE REDUCTION; EXOPHTHALMOS; EYE MOVEMENT DISORDER; EYE PAIN; EYELID EDEMA; FEMALE; HUMAN; IDIOPATHIC ORBITAL INFLAMMATORY DISEASE; LETTER; LYMPHOCYTIC INFILTRATION; OPHTHALMOPLEGIA; ORBIT INFLAMMATION; SHORT COURSE THERAPY; THYROID ADENOMA; VISUAL ACUITY;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; BLEPHAROPTOSIS; DRUG THERAPY, COMBINATION; EXOPHTHALMOS; EYE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; OPHTHALMOPLEGIA; ORBITAL PSEUDOTUMOR; PAIN; THYROID FUNCTION TESTS; THYROID NEOPLASMS; TIME FACTORS; VISUAL ACUITY;

EID: 73649123200     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2009.02188.x     Document Type: Letter

References (9)

1. Prendiville C, O'Doherty M, Moriaty P, Cassidy L. The use of infliximab in ocular inflammation. Br J Ophthalmol 2008, 92:823-5.
2. Harris GJ. Idiopathic orbital inflammation: a pathogenic construct and treatment strategy. Ophthal Plast Reconstr Surg 2006, 22:79-86.
3. Swamy BN, McCluskey P, Nemet A. Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol 2007, 91:1667-70.
4. Salvi M, Vannucchi G, Campi I. Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltration. Clin Immunol 2009, 131:360-5.
5. Garrity JA, Coleman AW, Matteson EL, Eggenberger ER, Waitzman DM. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol 2004, 138:925-30.
6. Sobrin L, Kim E, Christen W, Papadaki T, Letko E, Foster CS. Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol 2007, 125:895-900.
7. Miquel T, Abad S, Badelon I. Successful treatment of idiopathic orbital inflammatory inflammation with infliximab: an alternative to conventional steroid-sparing agents. Ophthal Plast Reconstr Surg 2008, 24:415-7.
8. Tallstedt L, Norberg R. Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophthalmol Vis Sci 1988, 29:175-84.
9. Lenderink T, Jager MJ, Bruijn JA, de Keizer RJ. Immunohistology of eye muscle in idiopathic orbital inflammatory disease (pseudotumour), Graves' ophthalmopathy and healthy controls. Graefes Arch Clin Exp Ophthalmol 1993, 231:99-103.